Announcement from Botuo Biotech on holding a performance briefing for the third quarter of 2025
Securities code: 688767 Securities abbreviation: Botuo Biotechnology Announcement number: 2025-042
Hangzhou Botuo Biotechnology Co., Ltd.
Announcement on Convening the Third Quarter 2025 Results Briefing
The company's board of directors and all directors guarantee that the announcement does not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law. Shanghai Stock Exchange SSE Roadshow CenterShanghai Stock Exchange SSE Roadshow CenterImportant reminder:
Meeting time: November 13, 2025 (Thursday) 9:00-10:00 am
Meeting place: SSE Roadshow Center (website: http://roadshow.sseinfo.com) Meeting method: SSE Roadshow Center online interaction
Investors can log in to the homepage of the Shanghai Securities Roadshow Center website before 16:00 on November 12, 2025 (Wednesday) and click on the "Question Pre-Collection" column or ask questions through the company's email address [email protected]. The company will answer questions of common concern to investors at the briefing meeting.
1. Type of briefing session
Hangzhou Botuo Biotechnology Co., Ltd. (hereinafter referred to as the "Company") has disclosed the company's 2025 third quarter report on the Shanghai Stock Exchange website (www.sse.com.cn) on October 30, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results and financial status in the third quarter of 2025, the company plans to hold 2025 on November 13, 2025 at 9:00-10:00 am. During the third quarter performance briefing of 2020, we will communicate on issues of concern to investors and answer questions of common concern to investors within the scope permitted by information disclosure. The company is now soliciting relevant questions from investors in advance for the third quarter 2025 performance briefing and listening to investors' opinions and suggestions.
2. Time and place of the briefing meeting
Convening time: 9:00-10:00 am on November 13, 2025 (Thursday)
Venue: SSE Roadshow Center (Website: http://roadshow.sseinfo.com)
Convening method: Shanghai Securities Roadshow Center online interaction
3. Participants:
The company's personnel attending this briefing include: Chairman Mr. Chen Yinlong, General Manager/Director Mr. Wu Shujiang, Deputy General Manager/Secretary of the Board of Directors Mr. Fei Qijun, Financial Director Ms. Yu Miaomiao, and Independent Director Mr. Duan Jianping (if there are special circumstances, the number of participants may be adjusted).
4. How investors participate in the meeting
Investors are welcome to log in to the SSE Roadshow Center (http://roadshow.sseinfo.com/) to participate online from 9:00-10:00 a.m. on November 13, 2025 (Thursday). The company will answer investors’ questions in a timely manner.
Investors can log in to the homepage of the SSE Roadshow Center website from November 6, 2025 (Thursday) to November 12 (Wednesday) before 16:00 and click the "Ask a Question Pre-Solicitation" column Project (https://roadshow.sseinfo.com/preCallQa), depending on the event time, select this event or ask questions via email [email protected]. The company will answer questions of common concern to investors at the briefing.
5. Contact person and consultation method
Contact Department: Board Office
Contact number: 0571-89058091
Contact email: [email protected]
6. Other matters
After the performance briefing is held, investors can check the status and main content of the performance briefing through the SSE Roadshow Center (http://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of Hangzhou Botuo Biotechnology Co., Ltd.
October 30, 2025